{
  "ptid_time": "041_S_4877_2012-08-30",
  "img_path": "/data/qiuhui/data/adni/images/041_S_4877/2012-08-30/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 36,665 mm³, 22.0% below the reference mean. With a Z-score of -0.64 (26.1th percentile), this represents normal volume ; hippocampal volume measures 5,403 mm³, 22.5% below the reference mean. With a Z-score of -1.94 (2.6th percentile), this represents moderate atrophy; whole brain volume measures 879,174 mm³, 14.6% below the reference mean. With a Z-score of -1.91 (2.8th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 84.4 years. Gender is Male. Education: 16 years. Handedness: Right. Race: Black or African American. Medical history: Head, Eyes, Ears, Nose and Throat; Endocrine-Metabolic; Renal-Genitourinary; Major Surgical Procedures. MMSE: 30.0. MoCA: 25.0. Logical Memory: 7.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.18 SUVR (normal ); Amyloid beta: 534.40 pg/mL (mild reduced); Total tau: 297.70 pg/mL (normal ); Phosphorylated tau: 34.33 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "Reasoning: The hippocampal and whole brain volumes show moderate atrophy (Z-scores -1.94 and -1.91, respectively), which is concerning for neurodegeneration. However, cognitive testing (MMSE 30, MoCA 25) is near-normal, and amyloid biomarkers (Aβ mildly reduced, AV45 normal) do not strongly support Alzheimer’s pathology. Elevated P-tau suggests possible tauopathy, but clinical symptoms are not yet pronounced.  \n\nDiagnosis: **MCI (Mild Cognitive Impairment)**  \nConfidence: **Medium** (due to conflicting biomarker and imaging findings with preserved cognition)",
  "timestamp": "2025-07-26T07:21:38.757257"
}